《新股消息》據報諾威健康叫停在港上市計劃
據《彭博通訊社》引述消息指,由於近期市況波動,美國私募基金TPG爲主要股東的生物科技公司諾威健康(Novotech Health)考慮暫緩在港上市計劃。
另外據《路透》旗下IFR引述諾威健康主席表示,現時將改爲透過私募市場融資,認爲將令公司加快增長和增加投資機會,未來會繼續檢視招股上市的可能性。
諾威健康早前已通過上市聆訊,消息人士指諾威健康上週開始進行預路演,但由於內地醫療健康市場氣氛疲弱,令投資者反應冷淡。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.